Compound Detail
CHEMBL134561
ICLAPRIM 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL134561 |
| Name | ICLAPRIM |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | HWJPWWYTGBZDEG-UHFFFAOYSA-N |
4
Targets
14
Activities
2
Assay Types
0
PK Parameters
20
Publications
6
Known Names
4
Indications
1
Mechanisms
Molecular Properties
354.4
MW (Da)
2.43
ALogP
7
HBA
2
HBD
105.5
PSA (Ų)
0.85
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Bacterial dihydrofolate reductase inhibitor | INHIBITOR | Dihydrofolate reductase | ✓ | ✓ |
Indications
Bacterial Infections Infections Skin Diseases Pneumonia, Ventilator-Associated
ATC Classification
J01EA03
iclaprim
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIBACTERIALS FOR SYSTEMIC USE
Activity Summary
IC50 8 meas. best 8.66
Ki 6 meas. best 10.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Dihydrofolate reductase CHEMBL1681620 | Ki | 10.1 | 9.7467 | 0.1 | 3 |
| Dihydrofolate reductase CHEMBL1681620 | IC50 | 8.66 | 8.2425 | 2.2 | 4 |
| Dihydrofolate reductase CHEMBL1809 | IC50 | 8.15 | 7.665 | 7.0 | 2 |
| Dihydrofolate reductase CHEMBL202 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Dihydrofolate reductase CHEMBL202 | Ki | 6.11 | 6.11 | 775.0 | 2 |
| Dihydrofolate reductase CHEMBL1926 | IC50 | 5.62 | 5.62 | 2400.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine